Pharma News

Abbott
Science has spoken: Abbott (NYSE: ABT) is, again, among the best science-based companies to work for in the world. For the 14th year, the journal Science today recognized Abbott on its Top Employers list, which is based on an evaluation of 23 characteristics including financial strength, easy adaptation to change, [...]
Fri, Oct 20, 2017
Source Pharma News
MSD is looking for innovators to solve 7 health-related challenges. One of them seeks to support anaesthesiologists with their continuous education (e.g. at the operation room) or their team building with surgeons. As a leading pharmaceutical company, MSD is aware of the need to incorporate innovation to deliver the best [...]
Fri, Oct 20, 2017
Source Pharma News
FDA
The U.S. Food and Drug Administration approved Yescarta (axicabtagene ciloleucel), a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of treatment. Yescarta, a chimeric antigen receptor (CAR) T cell [...]
Fri, Oct 20, 2017
Source Pharma News
Merck
Merck today announced that its Carlsbad, California-based manufacturing facility for the production of BioReliance® viral and gene therapy products has completed both a U.S. Food & Drug Administration (FDA) Pre-License inspection and a European Medicines Agency (EMA) Marketing Authorization Application inspection. [...]
Thu, Oct 19, 2017
Source Pharma News

(by Worldpharmanews)

Contact us
Dispopharm D&P Ltd.
Gewerbestrasse 18
4123 Allschwil
Switzerland
Phone: +41 61 487 96 36
Fax. +41 61 487 96 20
dispopharm@dispopharm.com
Dates
No dates at the moment.